GMI Certification
從細胞到個體、從個人到群體、從人群到動物、從體內保健到生態環保，GMI免疫調節蛋白全面地提供了良性循環的基礎。
GMI免疫調節蛋白有高度的協同性、安全性及有效性，已具備新藥開發的資格。
ABSTRACT：
The present invention relates to a new use of an immunomodulatory protein derived from Ganoderma or a recombinant or a composition thereof in reducing damage caused by fine particulate matter on embryos and offspring . Accordingly , the present invention suggests that the Ganoderma immunomodulatory protein administrated to pregnant animals can prevent neurological damages and reduce risk of disorders in embryos and offspring .
.jpg)
出處聯結：US11077168B2
